Target intelligence / Profile preview

Hepatocyte plasma membrane phospholipid bilayer

Molecular classification
Other, Lipid bilayer
01

Overview

The hepatocyte plasma membrane phospholipid bilayer is a specialized semi-permeable barrier that defines the boundary of the liver cell and its distinct functional domains, including the sinusoidal (basolateral) and canalicular (apical) membranes (Schulze et al., 2016, PMID: 27108171). It consists of a fluid mosaic of phospholipids, cholesterol, and glycolipids that provide the structural environment for essential membrane proteins such as the Sodium-taurocholate cotransporting polypeptide (NTCP) and various ATP-binding cassette (ABC) transporters (Trauner & Boyer, 2003, PMID: 12843410). This bilayer is vital for maintaining the electrochemical gradient, facilitating the uptake of metabolites, and enabling the secretion of bile components (Alberts et al., 2002, Molecular Biology of the Cell). Pathological changes in the lipid composition or physical properties of the membrane, such as increased rigidity or lipid peroxidation, are hallmarks of diseases like non-alcoholic steatohepatitis (NASH) and chronic viral hepatitis (Puri et al., 2007, PMID: 17654448). Although it is a complex cellular structure rather than a single molecular target, it is the site of action for membrane-stabilizing agents like ursodeoxycholic acid and is a critical barrier for the delivery of hepatotropic drugs and gene therapies (Roma et al., 2011, PMID: 21128895).

Other names
Hepatocyte plasma membraneLiver cell membrane bilayerHepatocyte surface membrane
02

Mechanism of action

Membrane stabilization and modulation of lipid composition to protect against lipotoxicity and bile acid-induced damage.

03

Biological functions

Selective permeabilityCell signalingBile secretionMetabolic regulationEndocytosis and exocytosis
04

Disease associations

Viral hepatitisNonalcoholic fatty liver disease (NAFLD)CholestasisCirrhosisNonalcoholic steatohepatitis (NASH)
05

Safety considerations

Non-specific membrane disruptionPotential for systemic toxicity if membrane integrity is compromised globally
06

Interacting drugs

Ursodeoxycholic acid

1 more in the full profile.

07

Biomarkers

Alanine aminotransferase (ALT)Aspartate aminotransferase (AST)

Beyond the preview

Go deeper on Hepatocyte plasma membrane phospholipid bilayer.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatocyte plasma membrane phospholipid bilayer.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call